Literature DB >> 28839831

The new treatment paradigm for Barrett's dysplasia.

Laurence Lovat.   

Abstract

Entities:  

Keywords:  BARRETT'S CARCINOMA; BARRETT'S OESOPHAGUS

Year:  2015        PMID: 28839831      PMCID: PMC5369462          DOI: 10.1136/flgastro-2015-100584

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


× No keyword cloud information.
  9 in total

1.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.

Authors:  N S Buttar; K K Wang; T J Sebo; D M Riehle; K K Krishnadath; L S Lutzke; M A Anderson; T M Petterson; L J Burgart
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

2.  Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.

Authors:  Robert A Ganz; Bergein F Overholt; Virender K Sharma; David E Fleischer; Nicholas J Shaheen; Charles J Lightdale; Stephen R Freeman; Ronald E Pruitt; Shiro M Urayama; Frank Gress; Darren A Pavey; M Stanley Branch; Thomas J Savides; Kenneth J Chang; V Raman Muthusamy; Anthony G Bohorfoush; Samuel C Pace; Steven R DeMeester; Viktor E Eysselein; Masoud Panjehpour; George Triadafilopoulos
Journal:  Gastrointest Endosc       Date:  2008-03-19       Impact factor: 9.427

3.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

4.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.

Authors:  Bergein F Overholt; Kenneth K Wang; J Steven Burdick; Charles J Lightdale; Michael Kimmey; Hector R Nava; Michael V Sivak; Norman Nishioka; Hugh Barr; Norman Marcon; Marcos Pedrosa; Mary P Bronner; Michael Grace; Michelle Depot
Journal:  Gastrointest Endosc       Date:  2007-07-23       Impact factor: 9.427

Review 5.  Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.

Authors:  Eric S Orman; Nan Li; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-02       Impact factor: 11.382

6.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.

Authors:  K Nadine Phoa; Frederike G I van Vilsteren; Bas L A M Weusten; Raf Bisschops; Erik J Schoon; Krish Ragunath; Grant Fullarton; Massimiliano Di Pietro; Narayanasamy Ravi; Mike Visser; G Johan Offerhaus; Cees A Seldenrijk; Sybren L Meijer; Fiebo J W ten Kate; Jan G P Tijssen; Jacques J G H M Bergman
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272

7.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059

8.  Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry.

Authors:  R J Haidry; M A Butt; J M Dunn; A Gupta; G Lipman; H L Smart; P Bhandari; L Smith; R Willert; G Fullarton; M Di Pietro; C Gordon; I Penman; H Barr; P Patel; N Kapoor; J Hoare; R Narayanasamy; Y Ang; A Veitch; K Ragunath; M Novelli; L B Lovat
Journal:  Gut       Date:  2014-12-24       Impact factor: 23.059

9.  Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience.

Authors:  J Ortiz-Fernández-Sordo; S Sami; R Mansilla-Vivar; J De Caestecker; A Cole; K Ragunath
Journal:  Frontline Gastroenterol       Date:  2015-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.